AXSOME THERAPEUTICS INC. - COMMON STOCK

Axsome Therapeutics Announces Results of the SUPPORT Survey of Patients with Major Depressive Disorder Presented at the American Society of Clinical Psychopharmacology Association (ASCP) 2022 Annual Meeting

06 6月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive Disorder

02 6月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Late-Breaking Presentations of Positive Results of the EVOLVE Trial of AXS-05 in Major Depressive Disorder After Prior Treatment Failures at the American Society of Clinical Psychopharmacology (ASCP) 2022 Annual Meeting

01 6月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical Psychiatry

31 5月 2022 06:39:37 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Completes U.S. Acquisition of Sunosi® (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea

09 5月 2022 07:57:19 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience

28 3月 2022 05:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Participate in the 1st Annual Needham Virtual Neuroscience Forum

11 3月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the Cowen 42nd Annual Health Care Conference

02 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

01 3月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022

15 2月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

11 2月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update

08 11月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Third Quarter 2021 Financial Results on November 8, 2021

20 10月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Expands Term Loan Facility with Hercules Capital to $300 Million

18 10月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Initiates SYMPHONY Phase 3 Trial of AXS-12 in Narcolepsy

16 9月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine

14 9月 2021 06:00:01 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder

23 8月 2021 05:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update

09 8月 2021 06:05:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics to Report Second Quarter 2021 Financial Results on August 9, 2021

15 7月 2021 06:00:00 条件 Nasdaq GlobeNewswire

Axsome Therapeutics Announces Planned NDA Submission for AXS-14 for the Management of Fibromyalgia

15 6月 2021 06:00:01 条件 Nasdaq GlobeNewswire